Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · IEX Real-Time Price · USD
7.56
-0.50 (-6.20%)
At close: Jul 2, 2024, 4:00 PM
7.80
+0.24 (3.17%)
After-hours: Jul 2, 2024, 5:20 PM EDT
Skye Bioscience Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Skye Bioscience stock have an average target of 19.67, with a low estimate of 14 and a high estimate of 25. The average target predicts an increase of 160.19% from the current stock price of 7.56.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SKYE stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +85.19% | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +85.19% | Jun 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $14 | Buy | Reiterates | $14 | +85.19% | Jun 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $21 | Buy | Initiates | $21 | +177.78% | May 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $25 | Buy | Initiates | $25 | +230.69% | Apr 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.97
from -5.37
EPS Next Year
-1.08
from -0.97
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.62 | -0.83 | -1.55 | -1.99 | -2.31 |
| Avg | -0.97 | -1.08 | -1.58 | -1.94 | -2.24 |
| Low | -1.45 | -1.28 | -1.58 | -1.86 | -2.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.